Lourie Zak has been appointed chief financial officer PBS Biotech, Inc. Ms. Zak takes over financial responsibility as the company brings its novel single-use bioreactors to market.
Ms. Zak joins the company from Amgen, where she held executive roles of increasing responsibility. For the past four years, Ms. Zak was executive director of finance for Amgen’s Global Commercial Operations at the Thousand Oaks, CA headquarters. She provided financial analysis and support to executive leadership in an environment that included product launches, global regulatory and reimbursement volatility, the enactment of U.S. healthcare reform and increased competition.
Prior to Amgen, she held controllership and vice president finance positions at various firms including DreamWorks SKG, eToys, and Sony Pictures Television International.
“Lourie is a great addition to the PBS Biotech executive team and will be a driver in managing our financial controls, providing financial leadership and decision support, and in securing capital for our growth,” said Dr. Brian Lee, president and co-founder of the company. “Her strong background in finance as well as knowledge of the biotech industry bring tremendous business depth and leadership experience that complements our team.”